BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,160,1532,068,1722,019,441
Cost of Revenue972,754930,085897,771
Gross Profit1,187,3991,138,0871,121,670
Operating Expenses
Research Development250,301205,864192,972
Selling General and Administrative808,942816,724761,990
Non Recurring11,50662,30562,305
Total Operating Expenses---
Operating Income or Loss116,65053,194166,708
Income from Continuing Operations
Total Other Income/Expenses Net3,06910,308831
Earnings Before Interest and Taxes119,71963,502167,539
Interest Expense21,91421,94221,692
Income Before Tax97,80541,560145,847
Income Tax Expense-24,44415,56036,608
Minority Interest---
Net Income From Continuing Ops122,24926,000109,239
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income122,24926,000109,239
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares122,24926,000109,239